<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Brain</journal-id>
<journal-title-group>
<journal-title>Molecular Brain</journal-title>
</journal-title-group>
<issn pub-type="epub">1756-6606</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31822292</article-id>
<article-id pub-id-type="pmc">6902552</article-id>
<article-id pub-id-type="publisher-id">527</article-id>
<article-id pub-id-type="doi">10.1186/s13041-019-0527-3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Peripheral blood metabolome predicts mood change-related activity in mouse model of bipolar disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9602-9518</contrib-id>
<name>
<surname>Hagihara</surname>
<given-names>Hideo</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6524-9398</contrib-id>
<name>
<surname>Horikawa</surname>
<given-names>Tomoyasu</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Irino</surname>
<given-names>Yasuhiro</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakamura</surname>
<given-names>Hironori K.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2595-7362</contrib-id>
<name>
<surname>Umemori</surname>
<given-names>Juzoh</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shoji</surname>
<given-names>Hirotaka</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yoshida</surname>
<given-names>Masaru</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9300-8268</contrib-id>
<name>
<surname>Kamitani</surname>
<given-names>Yukiyasu</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0137-8200</contrib-id>
<name>
<surname>Miyakawa</surname>
<given-names>Tsuyoshi</given-names>
</name>
<address>
<email>miyakawa@fujita-hu.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1761 798X</institution-id><institution-id institution-id-type="GRID">grid.256115.4</institution-id><institution>Division of Systems Medical Science, </institution><institution>Institute for Comprehensive Medical Science, Fujita Health University, </institution></institution-wrap>Kutsukake-cho, Toyoake, Aichi 470-1192 Japan </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2291 1583</institution-id><institution-id institution-id-type="GRID">grid.418163.9</institution-id><institution>Department of Neuroinformatics, </institution><institution>ATR Computational Neuroscience Laboratories, </institution></institution-wrap>Kyoto, 619-0288 Japan </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1092 3077</institution-id><institution-id institution-id-type="GRID">grid.31432.37</institution-id><institution>Division of Evidence-based Laboratory Medicine, </institution><institution>Kobe University, Graduate School of Medicine, </institution></institution-wrap>Kobe, 650-0017 Japan </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1092 3077</institution-id><institution-id institution-id-type="GRID">grid.31432.37</institution-id><institution>Division of Metabolomics Research, Department of Internal Related, </institution><institution>Kobe University Graduate School of Medicine, </institution></institution-wrap>Kobe, 650-0017 Japan </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1092 3077</institution-id><institution-id institution-id-type="GRID">grid.31432.37</institution-id><institution>Division of Gastroenterology, Department of Internal Medicine, </institution><institution>Kobe University Graduate School of Medicine, </institution></institution-wrap>Kobe, 650-0017 Japan </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0372 2033</institution-id><institution-id institution-id-type="GRID">grid.258799.8</institution-id><institution>Graduate School of Informatics, </institution><institution>Kyoto University, </institution></institution-wrap>Kyoto, 606-8501 Japan </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>10</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>12</volume>
<elocation-id>107</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>11</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Bipolar disorder is a major mental illness characterized by severe swings in mood and activity levels which occur with variable amplitude and frequency. Attempts have been made to identify mood states and biological features associated with mood changes to compensate for current clinical diagnosis, which is mainly based on patients’ subjective reports. Here, we used infradian (a cycle &gt; 24 h) cyclic locomotor activity in a mouse model useful for the study of bipolar disorder as a proxy for mood changes. We show that metabolome patterns in peripheral blood could retrospectively predict the locomotor activity levels. We longitudinally monitored locomotor activity in the home cage, and subsequently collected peripheral blood and performed metabolomic analyses. We then constructed cross-validated linear regression models based on blood metabolome patterns to predict locomotor activity levels of individual mice. Our analysis revealed a significant correlation between actual and predicted activity levels, indicative of successful predictions. Pathway analysis of metabolites used for successful predictions showed enrichment in mitochondria metabolism-related terms, such as “Warburg effect” and “citric acid cycle.” In addition, we found that peripheral blood metabolome patterns predicted expression levels of genes implicated in bipolar disorder in the hippocampus, a brain region responsible for mood regulation, suggesting that the brain–periphery axis is related to mood-change-associated behaviors. Our results may serve as a basis for predicting individual mood states through blood metabolomics in bipolar disorder and other mood disorders and may provide potential insight into systemic metabolic activity in relation to mood changes.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id>
<institution>Japan Society for the Promotion of Science</institution>
</institution-wrap>
</funding-source>
<award-id>25116526</award-id>
<award-id>15H01297</award-id>
<award-id>16H06462</award-id>
<award-id>25242078</award-id>
<principal-award-recipient>
<name>
<surname>Miyakawa</surname>
<given-names>Tsuyoshi</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id>
<institution>Japan Agency for Medical Research and Development</institution>
</institution-wrap>
</funding-source>
<award-id>579</award-id>
<principal-award-recipient>
<name>
<surname>Miyakawa</surname>
<given-names>Tsuyoshi</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par16">Mood naturally changes over time with variable amplitude and frequency, sometimes in an infradian (a cycle &gt; 24 h) manner [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. This is often accompanied by changes in physical activity [<xref ref-type="bibr" rid="CR3">3</xref>]. In bipolar disorder, unusual swings in mood and activity levels from depressive to manic states are core phenomenological and clinical features. Such exaggerated fluctuations in mood and the related activity can cause significant distress and/or social and occupational impairment, often leading to high direct and indirect health care costs [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Currently, the clinical assessment and management of these conditions mainly rely on clinicians’ interview and patients’ subjective description. To overcome the potential subjective biases, developing objective and quantitative measures is expected to compensate for the current procedures. To this end, substantial efforts have been invested into predicting mood states of patients with bipolar disorder based on biological features, such as heartbeat [<xref ref-type="bibr" rid="CR6">6</xref>], spontaneous speech [<xref ref-type="bibr" rid="CR7">7</xref>], and neural activity measured with functional magnetic resonance imaging [<xref ref-type="bibr" rid="CR8">8</xref>]. Meanwhile, molecular omics approaches, such as metabolomics and proteomics, with which hundreds of molecules can be targeted simultaneously, are being applied to gain more complete profiles of a wide range of biological conditions and diseases [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. However, such molecular omics-based approaches have not been well examined to predict mood states. While mood disorders are considered to be brain diseases, the use of peripheral samples has been desirable for clinical purposes, as the opportunity to obtain human brain tissues is limited [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
<p id="Par17">Previous studies have attempted to detect biomarkers for mood disorders in the blood by comparing the metabolomes of patients to control subjects [<xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. It is still not well understood whether or to what extent metabolomic alterations in peripheral blood are related to the shift of mood states. This may, in part, be due to the lack of animal models that exhibit behavioral phenotypes associated with infradian changes in mood states. We previously found that mice with the heterozygous knockout of the alpha-isoform of calcium/calmodulin-dependent protein kinase II (<italic>Camk2a</italic><sup>+/−</sup> mice) exhibit various dysregulated behaviors, including exaggerated cyclic mood-change-associated activity in an infradian manner, in which locomotor activity (LA) spontaneously and recurrently increases and decreases in a period of approximately 10–20 days [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Importantly, changes in the LA were correlated with changes in depression-like and anxiety-like behaviors [<xref ref-type="bibr" rid="CR14">14</xref>], suggesting that <italic>Camk2a</italic><sup>+/−</sup> mice are useful as an animal model which shows similar infradian oscillations of mood to those found in patients with bipolar disorder. CAMK2A is one gene suggested to be a candidate for bipolar disorder [<xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR18">18</xref>], and decreased CAMK2A mRNA has been found in the prefrontal cortex of patients with the disorder [<xref ref-type="bibr" rid="CR19">19</xref>]. <italic>Camk2a</italic><sup>+/−</sup> mice also harbor brain endophenotypes relevant to bipolar disorder, such as neuronal hyperexcitability [<xref ref-type="bibr" rid="CR20">20</xref>] and immaturity [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR23">23</xref>] in the hippocampus and decreased brain pH [<xref ref-type="bibr" rid="CR24">24</xref>]. These findings suggest that <italic>Camk2a</italic><sup>+/−</sup> mice provide a model for bipolar disorder which has good face and construct validity [<xref ref-type="bibr" rid="CR25">25</xref>].</p>
<p id="Par18">Using the <italic>Camk2a</italic><sup>+/−</sup> mice, we previously showed that gene expression patterns in the hippocampus, a brain region implicated in mood regulation, could retrospectively predict the LA level of individual mice by using statistical learning algorithm [<xref ref-type="bibr" rid="CR14">14</xref>]. We used cross-validated multivariate regression models to ensure the generalization ability of our prediction models. Generalization ability is the capacity to predict unseen samples, and ensuring and improving the generalization ability of models are believed to be crucial for practical use, including identification of subpopulations among patients with mood disorders [<xref ref-type="bibr" rid="CR26">26</xref>]. In the present study, using this strategy, we sought to determine whether metabolome patterns in peripheral blood can predict individual LA levels of the mice, which would have potential for future translational applications. We also investigated whether gene expression levels in the brain can be predicted by peripheral blood metabolome patterns, aiming to gain insights into the link between systemic metabolic pathways and the regulation of brain gene expression in relation to the infradian mood changes.</p>
</sec>
<sec id="Sec2">
<title>Materials and methods</title>
<sec id="Sec3">
<title>Animals</title>
<p id="Par19">Thirty-seven adult (&gt; 8 weeks old) male <italic>Camk2a</italic><sup>+/−</sup> mice were used [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Every effort was made to minimize the number of animals used.</p>
</sec>
<sec id="Sec4">
<title>Locomotor activity monitoring and blood sampling</title>
<p id="Par20">The LA data of <italic>Camk2a</italic><sup>+/−</sup> mice analyzed in this study were the same as was used in a previous study [<xref ref-type="bibr" rid="CR14">14</xref>]. Mice were singly housed with a 12 h light/dark cycle (lights on at 7:00 a.m.) and access to food and water ad libitum. The monitoring of LA and blood sampling was performed as previously described [<xref ref-type="bibr" rid="CR14">14</xref>]. Briefly, LA was monitored for 72–82 days through a system that automatically analyzes the distance traveled by a mouse in its home cage [<xref ref-type="bibr" rid="CR15">15</xref>]. Peripheral blood and brain tissue [<xref ref-type="bibr" rid="CR14">14</xref>], was collected at zeitgeber time (ZT) 6–7 (ZT0, lights on; ZT12, lights off) from mice with short or long distances traveled (assessed by distance traveled during the 24 h before ZT0 on the sampling day; Fig. <xref ref-type="fig" rid="Fig1">1</xref>a, b). In this way, mice were selected for the sampling such that their 24 h LA levels varied among the 37 mice (Fig. <xref ref-type="fig" rid="Fig1">1</xref>c). The 24 h LA was defined as distance traveled during the 24 h between ZT0 on the day before the sampling and ZT0 on the day of sampling. The 3 h LA was defined as distance traveled in every 3 h window before sampling (ZT6) (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Experimental workflow. <bold>a</bold> LA was longitudinally monitored, and blood was taken from each mouse ZT6–7. <bold>b</bold> 24 h LA, distance traveled during the 24 h before ZT0 on the sampling day; 3 h LAs, distances traveled of every 3 h window before sampling (ZT6). Black and white bars indicate dark and light period, respectively. <bold>c</bold> Variations in 24 h LA. Each dot indicates an individual mouse. Solid lines indicate average 24 h LA and dashed lines indicate the standard deviations for 35 mice. LA, locomotor activity; ZT, zeitgeber time</p></caption><graphic id="MO1" xlink:href="13041_2019_527_Fig1_HTML"></graphic></fig></p>
<p id="Par21">Mice were removed from the home cage, and immediately euthanatized by cervical dislocation. Blood was collected from the neck in tubes with Na-heparin and centrifuged (2200×<italic>g</italic> at 4 °C for 10 min) to prepare plasma. Plasma samples were stored at − 80 °C until use.</p>
</sec>
<sec id="Sec5">
<title>Gas chromatography mass spectrometry (GC/MS) analysis of blood samples</title>
<p id="Par22">GC/MS analysis was performed as described previously [<xref ref-type="bibr" rid="CR28">28</xref>] using a GCMS-QP2010 Ultra (Shimazu, Kyoto, Japan) with a fused silica capillary column (CP-SIL 8 CB low bleed/MS; 30 m × 0.25 mm inner diameter, film thickness 0.25 μm; Agilent Technologies, Palo Alto, CA, USA). Data processing was performed as described previously [<xref ref-type="bibr" rid="CR28">28</xref>]. 2-isopropylmalic acid was used as an internal standard. Two mice whose metabolite contents could not be measured due to unknown reasons were excluded from further analyses. Hence, LA and metabolome data from 35 mutant mice were processed for correlation and prediction analyses (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Table S1), as described below.</p>
</sec>
<sec id="Sec6">
<title>Brain gene expression data</title>
<p id="Par23">Expression microarray data of the hippocampal dentate gyrus [<xref ref-type="bibr" rid="CR29">29</xref>] was obtained from the 35 mice mentioned above. We used data that has been deposited at the Gene Expression Omnibus (GEO; accession number GSE68293) [<xref ref-type="bibr" rid="CR14">14</xref>]. The log<sub>2</sub>-transformed expression values were used for the prediction analyses.</p>
</sec>
<sec id="Sec7">
<title>Construction of models to predict LA</title>
<p id="Par24">The linear regression algorithm was used to predict LA (24 h LA and 3 h LAs; Fig. <xref ref-type="fig" rid="Fig1">1</xref>) and gene expression levels of individual mice from peripheral blood metabolome patterns using MATLAB [<xref ref-type="bibr" rid="CR14">14</xref>]. The prediction accuracy was evaluated by the leave-one-out cross-validation method and the feature selection for the prediction was conducted by the nested cross-validation method. Calculation details are included in the Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Supplementary Materials and Methods.</p>
</sec>
<sec id="Sec8">
<title>Pathway enrichment analysis</title>
<p id="Par25">To determine the characteristics of metabolites of interest, we used the default settings in MetaboAnalyst (version 4.0; <ext-link ext-link-type="uri" xlink:href="http://www.metaboanalyst.ca/">http://www.metaboanalyst.ca/</ext-link>) [<xref ref-type="bibr" rid="CR30">30</xref>], a comprehensive, web-based tool for metabolomics analysis and interpretation. Some feature names that had not been recognized in the query were modified if necessary, as suggested in the instructions.</p>
</sec>
</sec>
<sec id="Sec9">
<title>Results</title>
<sec id="Sec10">
<title>Locomotor activity can be predicted from blood metabolomic profiles</title>
<p id="Par26">Of the 106 metabolites tested, the concentrations of 16 features were correlated with 24 h LA (<italic>P</italic> &lt; 0.05, Pearson’s correlation; Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1). None of these survived false discovery rate correction for multiple tests (FDR; <italic>q</italic> value &lt; 0.1). To determine whether the metabolome patterns in peripheral blood could retrospectively predict the 24 h LA of individual mice, we performed linear regression analysis with the nested cross-validation method [<xref ref-type="bibr" rid="CR14">14</xref>]. Independent sets of mice were used for feature selection from entire set of 106 metabolites and model fitting in the inner cross-validation loop and testing the model performance in the outer cross-validation loop. Statistical evaluation of the prediction accuracy of the model revealed a significant correlation between the actual and the predicted 24 h LA (Fig. <xref ref-type="fig" rid="Fig2">2</xref>a), indicating that the metabolome patterns in the peripheral blood quantitatively predict the 24 h LA of individual mice. Thirty-three out of the 106 metabolites were selected to build the successful prediction model (Fig. <xref ref-type="fig" rid="Fig2">2</xref>b, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1).
<fig id="Fig2"><label>Fig. 2</label><caption><p>Metabolome patterns in the peripheral blood can predict 24 h LA in <italic>Camk2a</italic><sup>+/−</sup> mice. <bold>a</bold> Scatter plot showing a significant correlation between predicted and actual 24 h LA (<italic>N</italic> = 35 mice). <bold>b</bold> Feature preference for constructing the 24 h LA prediction model. <bold>c</bold> Results of pathway enrichment analysis for the metabolites used for constructing 24 h LA prediction model. The statistically enriched terms with raw <italic>P</italic>-value below 0.05 are shown. LA, locomotor activity</p></caption><graphic id="MO2" xlink:href="13041_2019_527_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec11">
<title>Mitochondrial alterations implicated in infradian oscillatory LA</title>
<p id="Par27">The prediction algorithm we used identified metabolome signatures related to infradian oscillatory LA by weighting metabolites according to their individual predictive strength (Fig. <xref ref-type="fig" rid="Fig2">2</xref>b). Next, we examined the weighted metabolites that were selected to predict the 24 h LA to gain insight into metabolic alterations related to changes in infradian oscillatory LA. Pathway enrichment analysis using a bioinformatics tool MetboAnalyst [<xref ref-type="bibr" rid="CR30">30</xref>] revealed that the set of metabolites exhibited enrichments in the Warburg effect, the citric acid cycle, and mitochondria-related pathway. These survived multiple comparison correction (FDR <italic>q</italic> value &lt; 0.05; Fig. <xref ref-type="fig" rid="Fig2">2</xref>c). Interestingly, all the terms were to mitochondrial functions (see Discussion), suggesting that mitochondrial function may change concomitantly with infradian oscillatory LA.</p>
</sec>
<sec id="Sec12">
<title>Peripheral blood metabolome predicts LA levels for longer time periods</title>
<p id="Par28">To investigate whether metabolome patterns in peripheral blood could predict the LA of the past several days, we constructed models for predicting the LA within the 3 days before sampling using a sliding time window (window size: 3 h, step size: 3 h; yielding 24 time windows) (3 h LAs; Fig. <xref ref-type="fig" rid="Fig1">1b</xref>). The actual and the predicted 3 h LAs were similar within the past 3 days in most mice, while differences between them were apparent in some mice (Fig. <xref ref-type="fig" rid="Fig3">3</xref>a, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2). Overall, statistical evaluation of prediction accuracy of the models detected significant correlations between the actual and the predicted 3 h LAs in 5 of the 24 time windows after FDR correction (time windows of 6–9 h: <italic>r</italic> = 0.46, <italic>P</italic> = 0.0049; 9–12 h: <italic>r</italic> = 0.49, <italic>P</italic> = 0.0025; 21–24 h: <italic>r</italic> = 0.41, <italic>P</italic> = 0.016; 51–54 h: <italic>r</italic> = 0.41, <italic>P</italic> = 0.016; 63–66 h: <italic>r</italic> = 0.51, <italic>P</italic> = 0.0017; Fig. <xref ref-type="fig" rid="Fig3">3</xref>b–g). The oldest time window with a significant correlation was from 63 to 66 h before sampling. These results suggest that multivariate patterns of the metabolome in the peripheral blood hold information about LA of at least the past 3 days. Out of the five time windows mentioned above, metabolites selected were similar in 3 h LA predictions of 6–9 h and 9–12 h time windows (as well as the 24 h LA prediction), and differed in other 3 h time windows (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3). Metabolites selected for the prediction of the oldest 3 h time window (63–66 h LA) were associated with aspartate-related pathways (unadjusted <italic>P</italic> &lt; 0.05; Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4), which differed from those for 24 h LA prediction (Fig. <xref ref-type="fig" rid="Fig2">2</xref>c).
<fig id="Fig3"><label>Fig. 3</label><caption><p>Prediction of 3 h LAs during the 3 days before sampling. <bold>a</bold> The prediction results of 6 mice are shown; the results of the remaining 29 mice are shown in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2. <bold>b</bold> Correlation coefficients between the actual and the predicted 3 h LAs in each time window. Dashed lines indicate <italic>P</italic> value of 0.05 and asterisks indicate significant correlations between actual and predicted 3 h LAs after FDR correction (<italic>q</italic> value &lt; 0.1). Black and white bars indicate dark and light periods, respectively. <bold>c</bold>–<bold>g</bold> Scatter plots of predicted and actual 3 h LAs of each mouse at the time windows indicated in b. LA, locomotor activity</p></caption><graphic id="MO3" xlink:href="13041_2019_527_Fig3_HTML"></graphic></fig></p>
</sec>
<sec id="Sec13">
<title>Hippocampal expression levels of the <italic>Arntl</italic> gene can be predicted from peripheral blood metabolome</title>
<p id="Par29">The regulation of mood is thought to involve the hippocampus [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>] and hippocampal expression of some circadian genes are closely related to infradian oscillation of LA in <italic>Camk2a</italic><sup>+/−</sup> mice [<xref ref-type="bibr" rid="CR14">14</xref>]. Consequently, using a prediction approach, we asked whether metabolome patterns in peripheral blood are related to hippocampal expression of circadian genes in relation to mood-change-associated activity. We used microarray-based gene expression data in the hippocampus of <italic>Camk2a</italic><sup>+/−</sup> mice that we had previously obtained from the same mice whose blood metabolome data was analyzed above [<xref ref-type="bibr" rid="CR14">14</xref>]. Cross-validated prediction models based on the blood metabolome data were constructed to predict expression levels of genes, focusing on seven circadian-related genes (<italic>Lonrf1</italic>, <italic>Cys1</italic>, <italic>Hist1h1c</italic>, <italic>Tef</italic>, <italic>Ak4</italic>, <italic>Arntl</italic>, and <italic>Sfpq</italic>), which were among the genes that were selected to predict the 24 h LA of <italic>Camk2a</italic><sup>+/−</sup> mice [<xref ref-type="bibr" rid="CR14">14</xref>]. Of the seven genes tested, <italic>Arntl</italic> and <italic>Sfpq</italic> expression levels could be predicted by blood metabolome patterns, which was determined by correlations between actual and predicted expression levels (<italic>P</italic> &lt; 0.05), and <italic>Arntl</italic> survived correction for multiple testing (Fig. <xref ref-type="fig" rid="Fig4">4a, b</xref>). Metabolites used for the successful prediction of hippocampal <italic>Arntl</italic> expression levels showed enrichment for mitochondria-related pathways (Fig. <xref ref-type="fig" rid="Fig4">4</xref>c, d).
<fig id="Fig4"><label>Fig. 4</label><caption><p>Prediction of hippocampal gene expression from peripheral blood metabolome. <bold>a</bold> Genes processed for this prediction analysis were provided from a previous study by Hagihara et al. [<xref ref-type="bibr" rid="CR14">14</xref>]. The correlation coefficients between actual and predicted expression levels of each gene are shown. Dashed lines indicatea a <italic>P</italic>-value of 0.05 and asterisks indicates significant correlations after Bonferroni correction for multiple testing (significance level: <italic>P</italic> &lt; 0.00714 = 0.05/7). <bold>b</bold> Scatter plot showing significant correlations between actual and predicted expression level of <italic>Arntl</italic>. The correlation was not due to outliers. <bold>c</bold> Feature preference for constructing the prediction model of <italic>Arntl</italic> expression level. <bold>d</bold> Results of pathway enrichment analysis for the metabolites used for constructing the prediction model of <italic>Arntl</italic> expression level. The statistical enriched terms with raw <italic>P</italic>-value below 0.05 are shown</p></caption><graphic id="MO4" xlink:href="13041_2019_527_Fig4_HTML"></graphic></fig></p>
</sec>
</sec>
<sec id="Sec14">
<title>Discussion</title>
<p id="Par30">In this study, we demonstrated for the first time that peripheral blood metabolomics in combination with a statistical learning algorithm can predict individual levels of mood-change-related activity using an animal model showing exaggerated infradian rhythm. It could be suggested that this result is simply a consequence of the metabolite secretions affected by LA immediately before sampling. However, considering that blood metabolome patterns could not predict LA during the 0–6 h immediately before sampling (Fig. <xref ref-type="fig" rid="Fig3">3</xref>b), this cannot be considered a major factor in determining the blood metabolome patterns. Thus, blood metabolome patterns may hold information about infradian states of LA oscillation during specific time windows that are several hours or days apart from the sampling time.</p>
<p id="Par31">Our prediction approach highlighted potential alterations in mitochondria metabolism concomitant with infradian mood change-related activity. The Warburg effect is a shift in metabolism towards aerobic glycolysis away from oxidative phosphorylation even in the presence of oxygen which is induced through mitochondrial dysfunction. It was first described in cancer, and studies of both patients’ brains and of mouse models have recently been suggested that it could be involved in several psychiatric disorders [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Alterations in metabolites related to the citric acid cycle have been found in peripheral blood and cerebrospinal fluid of patients with bipolar disorder [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. While these studies detected trait-related alterations and support the mitochondria hypothesis of bipolar disorder [<xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR38">38</xref>], our present study suggests that mitochondrial alterations are related to state-related alterations, or changes in mood states. However, the causal relationship between the mitochondria-related metabolic alterations in the blood and changes in LA levels remains unclear. Regarding state-related alterations, a recent meta-analysis indicated that blood levels of some inflammatory cytokines, such as IL-6 and sIL-6R, were increased in manic and euthymic states but not the depressive state compared to controls [<xref ref-type="bibr" rid="CR39">39</xref>]. Other study has shown that blood levels of IL-6 and IL-2 are positively correlated with mood symptoms, as indicated by the Young Mania Rating Scale [<xref ref-type="bibr" rid="CR40">40</xref>]. These findings suggest that inflammatory conditions could alter depending on affective states in bipolar disorder, with an enhanced inflammatory-related signature in manic states. Supporting these observations, we found that pyruvate, a metabolite suggested to be an endogenous anti-inflammatory molecule [<xref ref-type="bibr" rid="CR41">41</xref>], was negatively correlated with LA in <italic>Camk2a</italic><sup>+/−</sup> mice, and relatively low in manic-like states (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1). Although increased blood levels of pyruvate has implicated mitochondrial dysfunction in bipolar disorder, its significance on the pathogenesis of the disorder has remained unclear [<xref ref-type="bibr" rid="CR11">11</xref>]. Considering the findings of the present study and those of studies discussed above, mitochondrial destabilization may be intricately associated with pro- and anti-inflammatory balance in relation to changes in mood states as well as to the pathogenesis of the disorder [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
<p id="Par32">We found that blood metabolome patterns predicted 3 h LA at 3 days before sampling (63–66 h LA; Fig. <xref ref-type="fig" rid="Fig3">3</xref>b, c), and metabolites selected for the prediction showed enrichments in aspartate-related pathways (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4). Alterations in aspartate metabolism have been suggested in the brain and blood of patients with bipolar disorder [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]; however, their relations with mood changes are unknown. Considering that metabolites selected for the prediction of 3 h LA at 63–66 h before sampling and the related metabolic pathways were different from those for 24 h LA prediction (Fig. <xref ref-type="fig" rid="Fig2">2</xref>, Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Table S1), levels of a distinct set of blood metabolites and the metabolic pathways might retain information about LA during different and specific time windows.</p>
<p id="Par33">We also found that the peripheral blood metabolome can predict expression levels of the <italic>Arntl</italic> gene in the hippocampus, a brain region associated with mood regulation [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>], and that the metabolites that successfully predicted these levels showed enrichment for mitochondria-related pathways. These results suggest that systemic alterations in mitochondrial metabolism and hippocampal expression of <italic>Arntl</italic>, a candidate gene for bipolar disorder [<xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR46">46</xref>], may serve as a link for brain–periphery interactions in relation to mood-change-associated locomotor activity. Blood metabolites that change according to infradian cyclic locomotor activity could be associated not merely with the physical activity levels, but also potentially with hippocampal function in mood regulation via concomitant expression changes of the bipolar disorder candidate gene.</p>
<p id="Par34">In conclusion, the present study provided evidence that metabolome patterns in peripheral blood could be used as predictors of states of mood-change-related activity in this mouse model. As a limitation of this study, a recent history of physical activity might change peripheral metabolome patterns independent of the mood state, as intense or moderate exercise might affect mitochondria-related pathways in the brain, heart, and other organs in mice [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Among <italic>Camk2a</italic><sup>+/−</sup> mice, we previously showed that levels of infradian oscillatory LA in the home cages were associated with anxiety-like and depression-like behaviors [<xref ref-type="bibr" rid="CR14">14</xref>]. Although it is most likely that the LA state in the home cage reflects a certain state of mood in <italic>Camk2a</italic><sup>+/−</sup> mice, the effects of physical activity independent of the mood state on blood metabolome patterns should be considered as potential confounding factors in this study. This study, although limited to an animal model, may have potential for translational applications to human studies, as peripheral blood can be collected from living subjects in a minimally invasive way. States of mood and the related behaviors in human, especially patients with mood disorders, could potentially be retrospectively and prospectively predicted with blood samples through methods analogous to those used here. This may help to develop novel biologically-based methods for the diagnosis and treatment of bipolar disorder. To this end, further studies are needed to determine the most appropriate samples to collect (e.g., blood, saliva, urine, or skin), the appropriate processing methods (e.g., metabolomics, proteomics, or transcriptomics) and to optimize the prediction algorithm [<xref ref-type="bibr" rid="CR49">49</xref>].</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec15">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13041_2019_527_MOESM1_ESM.pdf"><caption><p><bold>Additional file 1. </bold>Supplementary Materials and Methods. <bold>Figure S1.</bold> Correlations between 24 h LA and levels of metabolites that were used for the prediction of 24 h LA. <bold>Figure S2.</bold> Prediction results of 3 h LAs from metabolome patterns in peripheral blood of <italic>Camk2a</italic><sup>+/−</sup> mice. Prediction of 3 h LAs during the 3 days before sampling for 29 mice. LA, locomotor activity. <bold>Figure S3.</bold> Metabolites used in prediction models that significantly predicted 3 h LA. Hierarchical clustering of metabolites based on their frequencies selected to build cross-validated prediction models for each time window of LA using R software (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>). LA, locomotor activity. <bold>Figure S4.</bold> Pathway enrichment analysis of the metabolites used for constructing a prediction model of 3 h LA at 63–66 h before sampling. The statistically enriched terms with raw <italic>P</italic>-values below 0.05 are shown.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13041_2019_527_MOESM2_ESM.xlsx"><caption><p><bold>Additional file 2: Table S1.</bold> The raw data used for this study.</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>Ak4</term>
<def>
<p id="Par2">Adenylate kinase 4</p>
</def>
</def-item>
<def-item>
<term>Arntl</term>
<def>
<p id="Par3">Aryl hydrocarbon receptor nuclear translocator-like</p>
</def>
</def-item>
<def-item>
<term>Camk2a</term>
<def>
<p id="Par4">alpha-isoform of calcium/calmodulin-dependent protein kinase II</p>
</def>
</def-item>
<def-item>
<term>Cys1</term>
<def>
<p id="Par5">Cystin 1</p>
</def>
</def-item>
<def-item>
<term>FDR</term>
<def>
<p id="Par6">False discovery rate</p>
</def>
</def-item>
<def-item>
<term>GC/MS</term>
<def>
<p id="Par7">Gas chromatography mass spectrometry</p>
</def>
</def-item>
<def-item>
<term>Hist1h1c</term>
<def>
<p id="Par8">Histone cluster 1, H1c</p>
</def>
</def-item>
<def-item>
<term>IL-6</term>
<def>
<p id="Par9">Interleukin-6</p>
</def>
</def-item>
<def-item>
<term>LA</term>
<def>
<p id="Par10">Locomotor activity</p>
</def>
</def-item>
<def-item>
<term>Lonrf1</term>
<def>
<p id="Par11">LON peptidase N-terminal domain and ring finger 1</p>
</def>
</def-item>
<def-item>
<term>Sfpq</term>
<def>
<p id="Par12">Splicing factor proline/glutamine rich</p>
</def>
</def-item>
<def-item>
<term>sIL-6R</term>
<def>
<p id="Par13">soluble interleukin-6 receptor</p>
</def>
</def-item>
<def-item>
<term>Tef</term>
<def>
<p id="Par14">Thyrotroph embryonic factor</p>
</def>
</def-item>
<def-item>
<term>ZT</term>
<def>
<p id="Par15">Zeitgeber time</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s13041-019-0527-3.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>The authors thank members of the Miyakawa lab for their assistance in animal husbandry.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>HH, HKN, JU and HS performed behavioral experiments and sampling of blood. YI and MY performed GC/MS analysis. TH, HKN and YK performed prediction analyses. HH, TH, HKN, YI, HS, YK and TM. wrote and edited the manuscript. HH. and TM designed the study. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This work was supported by JSPS Grant-in-Aid for Scientific Research on Innovative Areas Grant Number JP25116526, JP15H01297, and JP16H06462, JSPS KAKENHI Grant Number JP25242078, and JP15H05710, and AMED Strategic Research Program for Brain Sciences Grant Number JP18dm0107101.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>We provided the raw data used for this study in Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Table S1.</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par35">All animal experiments were approved by the Institutional Animal Care and Use Committee of Fujita Health University, based on the Law for the Humane Treatment and Management of Animals and the Standards Relating to the Care and Management of Laboratory Animals and Relief of Pain.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par36">Not applicable.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par37">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryson</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>DF</given-names>
</name>
</person-group>
<article-title>17-Ketosteroid excretion in a case of manic-depressive psychosis</article-title>
<source/>Lancet
          <year>1954</year>
<volume>267</volume>
<fpage>365</fpage>
<lpage>367</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(54)92667-7</pub-id>
<pub-id pub-id-type="pmid">13184682</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eastwood</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Whitton</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Peter</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Infradian rhythms. A comparison of affective disorders and normal persons</article-title>
<source/>Arch Gen Psychiatry
          <year>1985</year>
<volume>42</volume>
<fpage>295</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.1985.01790260093011</pub-id>
<pub-id pub-id-type="pmid">3977549</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belmaker</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>Bipolar Disorder</article-title>
<source/>N Engl J Med
          <year>2004</year>
<volume>351</volume>
<fpage>476</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra035354</pub-id>
<pub-id pub-id-type="pmid">15282355</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geddes</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Miklowitz</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Treatment of bipolar disorder</article-title>
<source/>Lancet
          <year>2013</year>
<volume>381</volume>
<fpage>1672</fpage>
<lpage>1682</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(13)60857-0</pub-id>
<pub-id pub-id-type="pmid">23663953</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleine-Budde</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Touil</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Moock</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bramesfeld</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kawohl</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Rössler</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Cost of illness for bipolar disorder: a systematic review of the economic burden</article-title>
<source/>Bipolar Disord
          <year>2014</year>
<volume>16</volume>
<fpage>337</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1111/bdi.12165</pub-id>
<pub-id pub-id-type="pmid">24372893</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valenza</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nardelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lanata</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gentili</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bertschy</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kosel</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Predicting mood changes in bipolar disorder through heartbeat nonlinear dynamics</article-title>
<source/>IEEE J Biomed Health Inform
          <year>2016</year>
<volume>20</volume>
<fpage>1034</fpage>
<lpage>1043</lpage>
<pub-id pub-id-type="doi">10.1109/JBHI.2016.2554546</pub-id>
<pub-id pub-id-type="pmid">28113920</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gui</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Detecting manic state of bipolar disorder based on support vector machine and gaussian mixture model using spontaneous speech</article-title>
<source/>Psychiatry Investig
          <year>2018</year>
<volume>15</volume>
<fpage>695</fpage>
<lpage>700</lpage>
<pub-id pub-id-type="doi">10.30773/pi.2017.12.15</pub-id>
<pub-id pub-id-type="pmid">29969852</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C-H</given-names>
</name>
<name>
<surname>Suckling</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lennox</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Ooi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bullmore</surname>
<given-names>ET</given-names>
</name>
</person-group>
<article-title>A quantitative meta-analysis of fMRI studies in bipolar disorder</article-title>
<source/>Bipolar Disord
          <year>2011</year>
<volume>13</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-5618.2011.00893.x</pub-id>
<pub-id pub-id-type="pmid">21320248</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guest</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Guest</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Martins-de</surname>
<given-names>SD</given-names>
</name>
</person-group>
<article-title>Making sense of blood-based proteomics and metabolomics in psychiatric research</article-title>
<source/>Int J Neuropsychopharmacol
          <year>2016</year>
<volume>19</volume>
<fpage>1</fpage>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernie</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Trethewey</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Krotzky</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Willmitzer</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Metabolite profiling: from diagnostics to systems biology</article-title>
<source/>Nat Rev Mol Cell Biol
          <year>2004</year>
<volume>5</volume>
<fpage>763</fpage>
<lpage>769</lpage>
<pub-id pub-id-type="doi">10.1038/nrm1451</pub-id>
<pub-id pub-id-type="pmid">15340383</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshimi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Futamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kakumoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Salehi</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Sellgren</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Holmén-Larsson</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder</article-title>
<source/>BBA Clin
          <year>2016</year>
<volume>5</volume>
<fpage>151</fpage>
<lpage>158</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbacli.2016.03.008</pub-id>
<pub-id pub-id-type="pmid">27114925</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaddurah-Daouk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>KRR</given-names>
</name>
</person-group>
<article-title>Metabolomics: a global biochemical approach to the study of central nervous system diseases</article-title>
<source/>Neuropsychopharmacology
          <year>2009</year>
<volume>34</volume>
<fpage>173</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2008.174</pub-id>
<pub-id pub-id-type="pmid">18843269</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinones</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Kaddurah-Daouk</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Metabolomics tools for identifying biomarkers for neuropsychiatric diseases</article-title>
<source/>Neurobiol Dis
          <year>2009</year>
<volume>35</volume>
<fpage>165</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2009.02.019</pub-id>
<pub-id pub-id-type="pmid">19303440</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Horikawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Umemori</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shoji</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kamitani</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Circadian gene circuitry predicts hyperactive behavior in a mood disorder mouse model</article-title>
<source/>Cell Rep
          <year>2016</year>
<volume>14</volume>
<fpage>2784</fpage>
<lpage>2796</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.067</pub-id>
<pub-id pub-id-type="pmid">27028761</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Maekawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kajii</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Soma</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders</article-title>
<source/>Mol Brain
          <year>2008</year>
<volume>1</volume>
<fpage>6</fpage>
<pub-id pub-id-type="doi">10.1186/1756-6606-1-6</pub-id>
<pub-id pub-id-type="pmid">18803808</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le-Niculescu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kurian</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Yehyawi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dike</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Edenberg</surname>
<given-names>HJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identifying blood biomarkers for mood disorders using convergent functional genomics</article-title>
<source/>Mol Psychiatry
          <year>2009</year>
<volume>14</volume>
<fpage>156</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2008.11</pub-id>
<pub-id pub-id-type="pmid">18301394</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ament</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Szelinger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Glusman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ashworth</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Akula</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare variants in neuronal excitability genes influence risk for bipolar disorder</article-title>
<source/>Proc Natl Acad Sci
          <year>2015</year>
<volume>112</volume>
<fpage>3576</fpage>
<lpage>3581</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1424958112</pub-id>
<pub-id pub-id-type="pmid">25730879</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>D-S</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>S-X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interactome analyses implicated CAMK2A in the genetic predisposition and pharmacological mechanism of bipolar disorder</article-title>
<source/>J Psychiatr Res
          <year>2019</year>
<volume>115</volume>
<fpage>165</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2019.05.024</pub-id>
<pub-id pub-id-type="pmid">31150948</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xing</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hough</surname>
<given-names>C</given-names>
</name>
<name>
<surname>O’Grady</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Decreased prefrontal CaMKII alpha mRNA in bipolar illness</article-title>
<source/>Neuroreport
          <year>2002</year>
<volume>13</volume>
<fpage>501</fpage>
<lpage>505</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-200203250-00029</pub-id>
<pub-id pub-id-type="pmid">11930170</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mertens</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q-W</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>DX</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder</article-title>
<source/>Nature
          <year>2015</year>
<volume>527</volume>
<fpage>95</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1038/nature15526</pub-id>
<pub-id pub-id-type="pmid">26524527</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kogan</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tajinda</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The immature dentate gyrus represents a shared phenotype of mouse models of epilepsy and psychiatric disease</article-title>
<source/>Bipolar Disord
          <year>2013</year>
<volume>15</volume>
<fpage>405</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="doi">10.1111/bdi.12064</pub-id>
<pub-id pub-id-type="pmid">23560889</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohira</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Transcriptomic evidence for immaturity induced by antidepressant fluoxetine in the hippocampus and prefrontal cortex</article-title>
<source/>Neuropsychopharmacol Rep
          <year>2019</year>
<volume>39</volume>
<fpage>78</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1002/npr2.12048</pub-id>
<pub-id pub-id-type="pmid">30772953</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kogan</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>AK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detection of an immature dentate gyrus feature in human schizophrenia/bipolar patients</article-title>
<source/>Transl Psychiatry
          <year>2012</year>
<volume>2</volume>
<fpage>e135</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2012.56</pub-id>
<pub-id pub-id-type="pmid">22781168</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Catts</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Katayama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shoji</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>FL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Decreased brain pH as a shared endophenotype of psychiatric disorders</article-title>
<source/>Neuropsychopharmacology
          <year>2018</year>
<volume>43</volume>
<fpage>459</fpage>
<pub-id pub-id-type="doi">10.1038/npp.2017.167</pub-id>
<pub-id pub-id-type="pmid">28776581</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Immature dentate gyrus: an endophenotype of neuropsychiatric disorders</article-title>
<source/>Neural Plast
          <year>2013</year>
<volume>2013</volume>
<fpage>e318596</fpage>
<pub-id pub-id-type="doi">10.1155/2013/318596</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Passos</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Mwangi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M-J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>XY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identifying a clinical signature of suicidality among patients with mood disorders: a pilot study using a machine learning approach</article-title>
<source/>J Affect Disord
          <year>2016</year>
<volume>193</volume>
<fpage>109</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2015.12.066</pub-id>
<pub-id pub-id-type="pmid">26773901</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohira</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Toyama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Expression of the AMPA receptor subunits GluR1 and GluR2 is associated with granule cell maturation in the dentate gyrus</article-title>
<source/>Front Neurosci
          <year>2011</year>
<volume>5</volume>
<fpage>100</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2011.00100</pub-id>
<pub-id pub-id-type="pmid">21927594</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yonezawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nishiumii</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kitamoto-Matsuda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Morimoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum and tissue metabolomics of head and neck cancer</article-title>
<source/>Cancer Genomic Proteomic
          <year>2013</year>
<volume>10</volume>
<fpage>233</fpage>
<lpage>238</lpage>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Toyama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Dissection of hippocampal dentate gyrus from adult mouse</article-title>
<source/>J Vis Exp
          <year>2009</year>
<volume>33</volume>
<fpage>1543</fpage>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Soufan</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Caraus</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bourque</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis</article-title>
<source/>Nucleic Acids Res
          <year>2018</year>
<volume>46</volume>
<fpage>W486</fpage>
<lpage>W494</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gky310</pub-id>
<pub-id pub-id-type="pmid">29762782</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>David</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Samuels</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Rainer</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>David</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gardier</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Implications of the functional integration of adult-born hippocampal neurons in anxiety-depression disorders</article-title>
<source/>Neurosci Rev J Bringing Neurobiol Neurol Psychiatry
          <year>2010</year>
<volume>16</volume>
<fpage>578</fpage>
<lpage>591</lpage>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samuels</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Hen</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Neurogenesis and affective disorders</article-title>
<source/>Eur J Neurosci
          <year>2011</year>
<volume>33</volume>
<fpage>1152</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07614.x</pub-id>
<pub-id pub-id-type="pmid">21395859</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>J-N</given-names>
</name>
</person-group>
<article-title>Warburg effect hypothesis in autism spectrum disorders</article-title>
<source/>Mol Brain
          <year>2018</year>
<volume>11</volume>
<fpage>1</fpage>
<pub-id pub-id-type="doi">10.1186/s13041-017-0343-6</pub-id>
<pub-id pub-id-type="pmid">29301575</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshimi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Futamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bergen</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Iwayama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ishima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sellgren</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>1504</fpage>
<lpage>1510</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2015.217</pub-id>
<pub-id pub-id-type="pmid">26782057</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction in bipolar disorder</article-title>
<source/>Bipolar Disord
          <year>2000</year>
<volume>2</volume>
<fpage>180</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1034/j.1399-5618.2000.020305.x</pub-id>
<pub-id pub-id-type="pmid">11256685</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction and bipolar disorder</article-title>
<source/>Curr Top Behav Neurosci
          <year>2011</year>
<volume>5</volume>
<fpage>187</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1007/7854_2010_52</pub-id>
<pub-id pub-id-type="pmid">25236556</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Walder</surname>
<given-names>K</given-names>
</name>
<name>
<surname>McGee</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Tye</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A model of the mitochondrial basis of bipolar disorder</article-title>
<source/>Neurosci Biobehav Rev
          <year>2017</year>
<volume>74</volume>
<fpage>1</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2017.01.014</pub-id>
<pub-id pub-id-type="pmid">28093238</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Current understanding of bipolar disorder: Toward integration of biological basis and treatment strategies</article-title>
<source/>Psychiatry Clin Neurosci
          <year>2019</year>
<volume>73</volume>
<fpage>526</fpage>
<pub-id pub-id-type="doi">10.1111/pcn.12852</pub-id>
<pub-id pub-id-type="pmid">31021488</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldsmith</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Rapaport</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<article-title>A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>1696</fpage>
<lpage>1709</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.3</pub-id>
<pub-id pub-id-type="pmid">26903267</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brietzke</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stertz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Kauer-Sant’Anna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mascarenhas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Escosteguy Vargas</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<source/>J Affect Disord
          <year>2009</year>
<volume>116</volume>
<fpage>214</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2008.12.001</pub-id>
<pub-id pub-id-type="pmid">19251324</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>UN</given-names>
</name>
</person-group>
<article-title>Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule</article-title>
<source/>Med Sci Monit Int Med J Exp Clin Res
          <year>2006</year>
<volume>12</volume>
<fpage>RA79</fpage>
<lpage>RA84</lpage>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Decreased mitochondrial function and increased brain inflammation in bipolar disorder and other neuropsychiatric diseases</article-title>
<source/>J Clin Psychopharmacol
          <year>2011</year>
<volume>31</volume>
<fpage>685</fpage>
<lpage>687</lpage>
<pub-id pub-id-type="doi">10.1097/JCP.0b013e318239c190</pub-id>
<pub-id pub-id-type="pmid">22020358</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winsberg</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Sachs</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tate</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Adalsteinsson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Spielman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ketter</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder</article-title>
<source/>Biol Psychiatry
          <year>2000</year>
<volume>47</volume>
<fpage>475</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-3223(99)00183-3</pub-id>
<pub-id pub-id-type="pmid">10715353</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mansour</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Logue</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chowdari</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Dayal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kupfer</surname>
<given-names>DJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia</article-title>
<source/>Genes Brain Behav
          <year>2006</year>
<volume>5</volume>
<fpage>150</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2005.00147.x</pub-id>
<pub-id pub-id-type="pmid">16507006</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nievergelt</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Kripke</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>TB</given-names>
</name>
<name>
<surname>Burg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Remick</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Sadovnick</surname>
<given-names>AD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2006</year>
<volume>141B</volume>
<fpage>234</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30252</pub-id>
<pub-id pub-id-type="pmid">16528748</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wittke-Thompson</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Badner</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Potash</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Willour</surname>
<given-names>VL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2008</year>
<volume>147B</volume>
<fpage>1047</fpage>
<lpage>1055</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30714</pub-id>
<pub-id pub-id-type="pmid">18228528</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguiar</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Tuon</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pinho</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Andreazza</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Kapczinski</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intense exercise induces mitochondrial dysfunction in mice brain</article-title>
<source/>Neurochem Res
          <year>2008</year>
<volume>33</volume>
<fpage>51</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-007-9406-x</pub-id>
<pub-id pub-id-type="pmid">17619145</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boveris</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Systemic and mitochondrial adaptive responses to moderate exercise in rodents</article-title>
<source/>Free Radic Biol Med
          <year>2008</year>
<volume>44</volume>
<fpage>224</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.08.015</pub-id>
<pub-id pub-id-type="pmid">18191758</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayashi-Takagi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vawter</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research</article-title>
<source/>Biol Psychiatry
          <year>2014</year>
<volume>75</volume>
<fpage>920</fpage>
<lpage>928</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.09.035</pub-id>
<pub-id pub-id-type="pmid">24286759</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>